| abstract |
The present invention provides novel peptide agents, for example, antibodies and antigen-binding fragments thereof that bind to hemagglutinin protein of influenza virus, and methods of using them. The disclosure relates, at least in part, to human anti-HA antibodies that include the functional and structural properties disclosed herein, such as antibodies that bind to conserved regions or epitopes on influenza viruses and Based on the discovery of their use. Accordingly, the present disclosure features binding agents that bind to hemagglutinin (HA) derived from influenza virus, such as antibody molecules, or preparations or isolated preparations thereof. [Selection figure] None |